Stockscreener 앱 받기
23.65
0.96%
-0.23
전일 마감가:
$23.88
열려 있는:
$23.76
하루 거래량:
2.02M
Relative Volume:
1.49
시가총액:
$2.45B
수익:
$71.78M
순이익/손실:
$-295.28M
주가수익비율:
-7.4849
EPS:
-3.1597
순현금흐름:
$-271.85M
1주 성능:
-7.25%
1개월 성능:
-9.97%
6개월 성능:
+63.78%
1년 성능:
+171.84%
1일 변동 폭
$23.02
$23.93
1주일 범위
$23.02
$25.96
52주 변동 폭
$8.215
$28.23
누릭스 테라퓨틱스 Stock (NRIX) Company Profile
명칭
Nurix Therapeutics Inc
전화
(415) 660-5320
주소
1600 SIERRA POINT PKWY, BRISBANE
Compare NRIX vs VRTX, REGN, MRNA, ARGX, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NRIX
Nurix Therapeutics Inc
|
23.65 | 2.45B | 71.78M | -295.28M | -271.85M | -3.1597 |
VRTX
Vertex Pharmaceuticals Inc
|
522.38 | 132.40B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
796.02 | 81.95B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
194.82 | 77.78B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
962.22 | 60.20B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
199.86 | 42.84B | 742.00K | -1.37B | -1.07B | -7.0731 |
누릭스 테라퓨틱스 Stock (NRIX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-08 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-24 | 재개 | Truist | Buy |
| 2025-10-21 | 개시 | Mizuho | Outperform |
| 2025-03-17 | 개시 | Leerink Partners | Market Perform |
| 2024-12-10 | 개시 | BTIG Research | Buy |
| 2024-12-06 | 개시 | BMO Capital Markets | Outperform |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-10-11 | 개시 | Jefferies | Buy |
| 2024-09-06 | 재개 | Robert W. Baird | Outperform |
| 2024-07-31 | 개시 | Truist | Buy |
| 2023-06-26 | 재개 | Oppenheimer | Outperform |
| 2023-03-09 | 개시 | Barclays | Overweight |
| 2023-02-28 | 개시 | Oppenheimer | Outperform |
| 2022-10-11 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-05-31 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-02-10 | 개시 | Wells Fargo | Equal Weight |
| 2021-12-29 | 개시 | H.C. Wainwright | Buy |
| 2021-10-14 | 개시 | SVB Leerink | Outperform |
| 2021-06-04 | 재개 | Robert W. Baird | Outperform |
| 2021-04-30 | 재개 | Piper Sandler | Overweight |
| 2021-04-30 | 개시 | RBC Capital Mkts | Outperform |
| 2021-04-14 | 개시 | Berenberg | Buy |
| 2020-11-19 | 개시 | Robert W. Baird | Outperform |
| 2020-08-18 | 개시 | JP Morgan | Overweight |
| 2020-08-18 | 개시 | Needham | Buy |
| 2020-08-18 | 개시 | Piper Sandler | Overweight |
| 2020-08-18 | 개시 | Stifel | Buy |
모두보기
누릭스 테라퓨틱스 주식(NRIX)의 최신 뉴스
842,089 Shares in Nurix Therapeutics, Inc. $NRIX Bought by Bank of America Corp DE - MarketBeat
More than 5% of Nurix Therapeutics (NRIX) is reported by three parties, but one fund holds the shares. - Stock Titan
Trading Systems Reacting to (NRIX) Volatility - Stock Traders Daily
Nurix Therapeutics, Inc. (NRIX) Stock Price, News, Quote & History - Yahoo! Finance Canada
AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates - Zacks Investment Research
Nurix Therapeutics, Inc. (NRIX) Stock Analysis: A Biotech Gem With A 33% Upside Potential - DirectorsTalk Interviews
Behavioral Patterns of NRIX and Institutional Flows - Stock Traders Daily
Nurix Therapeutics Stock Price Forecast. Should You Buy NRIX? - StockInvest.us
We Think Nurix Therapeutics (NASDAQ:NRIX) Can Afford To Drive Business Growth - Moomoo
Nurix Therapeutics, Inc. (NRIX) Latest Stock News & Headlines - Yahoo Finance
Here's Why You Should Add NRIX Stock to Your Portfolio Now - Yahoo Finance
Transcript : Nurix Therapeutics, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-08-2026 03 - marketscreener.com
Nurix Therapeutics (NRIX) Upgraded to Buy: Here's Why - Yahoo Finance
Nurix Therapeutics (NRIX) Advances 0.50% to $26.26 as Shares Test Range Between Support and ResistanceWyckoff Spring - dars.gov.et
Nurix Therapeutics at Wells Fargo conference: pipeline, deal momentum By Investing.com - Investing.com India
Nurix Therapeutics at Wells Fargo conference: pipeline, deal momentum - investing.com
Legal & General Group Plc Buys Shares of 72,026 Nurix Therapeutics, Inc. $NRIX - MarketBeat
Wall Street Zen Downgrades Nurix Therapeutics (NASDAQ:NRIX) to Sell - MarketBeat
Bank of New York Mellon Corp Purchases New Shares in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics chief legal officer sells over $149k in shares By Investing.com - Investing.com South Africa
Braidwell LP Cuts Position in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Nurix Therapeutics chief legal officer sells over $149k in shares - Investing.com
The Manufacturers Life Insurance Company Acquires New Holdings in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Man Group plc Makes New $2.08 Million Investment in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Alyeska Investment Group L.P. Takes $3.35 Million Position in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix CSO Gwenn Hansen sells $36,982 in stock - Investing.com
Nurix Therapeutics (NASDAQ:NRIX) Insider Gwenn Hansen Sells 1,452 Shares of Stock - MarketBeat
Nurix Therapeutics to Participate in Upcoming September Investor Conferences - Investing News Network
BlackRock Inc. Buys New Position in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Deutsche Bank AG Takes Position in Nurix Therapeutics, Inc. $NRIX - MarketBeat
58,898 Shares in Nurix Therapeutics, Inc. $NRIX Bought by Polymer Capital Management HK LTD - MarketBeat
Nurix (NRIX) Financial Update: EPS Comes in Below Forecast; Stock Move: The Stock Loses 2.40%Annual Earnings Summary - careplusvn.com
Bank of America Corp DE Purchases 65,595 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics Announces Appointment of Wes Burwell as Chief Human Resources Officer - Sahm
Edmond DE Rothschild Holding S.A. Invests $2.18 Million in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix (NRIX) Price: Ends Lower by 1.22% at $26.72 on the Day; Current Setup: Traders Can Monitor the $25.38-$28.06 Range in the Available RecordSector Neutral Pair - careplusvn.com
Deep Track Capital, LP Expands Nurix Therapeutics Inc (NRIX) Sta - GuruFocus
Top BridgeBio Oncology Therapeutics (BBOT) Competitors 2026 - MarketBeat
Press Release: Nurix Therapeutics Announces Appointment of Wes Burwell as Chief Human Resources Officer - Moomoo
Nurix Therapeutics (NASDAQ:NRIX) Reaches New 12-Month HighShould You Buy? - MarketBeat
Nurix (NRIX) Results Review: The EPS Result Is Below Expectation for the Current Session; Post-Earnings: Shares Fall 0.88%EPS Growth Rate - Vinanet
Nurix Therapeutics (NRIX) Starts Phase 3 And Lands Sanofi Milestone, Is The Valuation About Right? - Sahm
Handelsbanken Fonder AB Buys 86,000 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics (NRIX) Is Up 6.0% After Milestone From Sanofi And Phase 3 Start With Roche - webull.com
Nurix Therapeutics stock hits 52-week high at $26.40 By Investing.com - Investing.com Nigeria
Nurix Therapeutics stock hits 52-week high at $26.40 - Investing.com
Sei Investments Co. Buys 46,132 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
Understanding the Setup: (NRIX) and Scalable Risk - Stock Traders Daily
Nurix Therapeutics (NASDAQ:NRIX) Reaches New 1-Year High After Analyst Upgrade - MarketBeat
NRIX Maintained by RBC Capital -- Price Target Raised to $36 - GuruFocus
누릭스 테라퓨틱스 (NRIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
누릭스 테라퓨틱스 주식 (NRIX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Ring Christine | Chief Legal Officer |
Sep 02 '26 |
Sale |
25.76 |
5,787 |
149,072 |
9,110 |
1.11%
1.87%
자본화:
|
볼륨(24시간):